7Josbi A, Vron J/J, Unge J, et al. Design and synthesis of P1 P3 macrocyelic tertiary-alcohol-comprising HIV-1 protease inhlbi- torsi J]. J Med Chem,2013,56(22) : 8999 -9007. 被引量：1
8Katende-Kyenda NL, Lubbe MS, Serfontein JHP,et al. Determining potential drug-drug interactions between lopinavir/ritonavir and other antiretrovirals and prescribed daily doses in a section of the private health care sector in South Africa[ J]. Afr J Pha Pharma- col,2013,7(41 ) : 2727 -2733. 被引量：1
9Aspiroz EL, Cabrera Figueroa SE, Cruz R, et al. Toxicogenetics of lopinavir/ritonavir in HIV-infected European patients J ]. Person- alized Medicine ,2014, l 1 ( 3 ) :263 - 272. 被引量：1
10Bellani P, Frigerio M, Castoldi P. Process for the synthesis of ritonavir: US,6407252B1 [ p]. 2002 -06 - 18. 被引量：1
